Last reviewed · How we verify

NCT02313597

Video-assisted Anal Fistula Treatment Versus Seton in the Management of High Peri Anal Fistula

Completed NA Results posted Last updated 11 March 2021
What this trial tests

NA trial testing SETON in Post Operative Pain in 80 participants. Completed in 31 July 2020.

Timeline
1 August 2014
Primary endpoint
31 July 2020
31 July 2020

Quick facts

Lead sponsorDr. SamiUllah
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date1 August 2014
Primary completion31 July 2020
Estimated completion31 July 2020
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Dr. SamiUllah

Who can join

Adults 15 to 60, any sex, with Post Operative Pain or Recurrence. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants With Recurrence of Disease or Fistula Primary · 3 years postoperatively

Number of Participants with Recurrence of Disease or Fistula 3 Years After Treatment

GroupValue95% CI
SETON5
VAAFT10
Duration of Surgery Secondary · Time from beginning of surgery to end of surgery,assessed up to 180 minutes

Duration of surgery measured upto 180 minutes

GroupValue95% CI
SETON36.97± 12.98
VAAFT78.60± 26.24
Pain Score Secondary · 12 hours after surgery

Pain score measured through visual analog score with 1 being minimum and 10 being maximum. Lesser value represents better outcome and greater value shows worse outcome.

GroupValue95% CI
SETON2.82± 1.58
VAAFT4.22± 1.83
Time to Return to Work Secondary · up to 4 weeks
GroupValue95% CI
SETON9.27± 2.06
VAAFT7.42± 1.78
Time to Healing of Fistula Secondary · up to 12 weeks
GroupValue95% CI
SETON9.7± 1.87
VAAFT5.75± 1.17

Sponsor's own description

Anal fistula is the most common Peri anal disease. It's a disease with an incidence of 9 in 100,000. Anal fistula is classified on the basis of its location into high and low anal fistula, above or below dentate line respectively. Multiple series have shown that the formation of a fistula tract following anorectal abscess occurs in 7-40% of cases. There are typically 8-10 anal crypt glands at the level of the dentate line in the anal canal arranged circumstantially. These glands afford a path for infecting organisms to reach the intramuscular spaces. The cryptoglandular hypothesis states that an infection begins in the anal canal glands and progresses into the muscular wall of the anal sphincters to cause an anorectal abscess. According to internal opening many author proposed certain classification but the standardized in all of them is Park's classification, so this study categorized the patient through this classification. There are four types of fistula-in-ano in Park's Classification intersphincteric (between internal and external sphincters is 70%), transsphincteric (across external sphincters is 25%), suprasphincteric (over sphincters), and extrasphincteric(above and through levator ani).High anal fistula is considered to be difficult to treat because of its location.This study diagnosed the internal opening of high perianal with the help of endoluminal ultrasound and MRI. Classic method of its treatment are fistulotomy, fistulectomy and Setone placement but these are associated with lots of complication like fecal incontinence,recurrence,pain.Therefore many method have been recently devised including Ligation of intersphincteric fistula tract (Lift), glue repair and flap advancement.Another recently introduced method for its treatment is Video-assisted anal fistula treatment (VAAFT) proposed by P. Meinero which has been associated with less complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Post Operative Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02313597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing